Diffusion-kurtosis magnetic resonance imaging of the brain in the differential diagnostics of metastases of tumors of various primary localization
- Authors: Garanina N.V.1, Dolgushin M.B.2, Fadeeva L.M.3, Pogosbekyan E.L.3, Sashin D.V.1, Nechipay E.A.1, Dvoryanchikov A.V.2
-
Affiliations:
- N.N. Blokhin National Medical Research Center of Oncology
- Federal Center of Brain Research and Neurotechnologies
- N.N. Burdenko National Scientific and Practical Center for Neurosurgery
- Issue: Vol 14, No 4 (2023)
- Pages: 34-48
- Section: Original Study Articles
- URL: https://journals.rcsi.science/clinpractice/article/view/253944
- DOI: https://doi.org/10.17816/clinpract454763
- ID: 253944
Cite item
Full Text
Abstract
Background: Metastatic brain lesions lead to the most unfavorable prognosis for the course of an oncological disease. Most often, brain metastases arise from primary tumors such as lung cancer, breast cancer, and melanoma. Of particular interest are groups of secondary intracranial tumors without an identified primary focus. Methods of non-invasive differential diagnosis based on a possible histological affiliation, including diffusion-kurtosis magnetic resonance imaging, can improve the diagnostic search for the primary tumor. Aim: The aim of this study is to improve the quality of differential diagnosis for brain metastases of tumors of different primary localization by introducing the diffusion-kurtosis magnetic resonance imaging technique into the magnetic resonance scanning protocol. Methods: Our work included studies of 60 patients who underwent examination and treatment at the N.N. Blokhin National Research Medical Center of Oncology of the Ministry of Health of Russia from October 2019 to March 2022. According to magnetic resonance imaging, metastatic formations were detected in the brain of the patients, with different localizations of the primary tumor. 20 patients were diagnosed with lung cancer (33.3%), 20 patients with breast cancer (33.3%) and 20 patients with melanomas (33.3%). We evaluated the tumor size, diffusion and kurtosis parameters, such as the mean kurtosis, axial kurtosis, radial kurtosis, kurtosis anisotropy, radial diffusion, and fractional anisotropy, and relative anisotropy, axial diffusion of the extra-axonal fluid, radial diffusion of the extra-axonal fluid, axonal fluid fraction, and tortuosity of the diffusion trajectory. Results: Statistically significantly (p <0.05) differing parameters of diffusion and kurtosis in the comparative evaluation of the above indicators were identified in the structure associated with melanoma and lung cancer axial diffusion, fractional anisotropy, relative anisotropy, radial kurtosis and tortuosity of the diffusion trajectory, as well as in the structure of melanoma and breast cancer — axial diffusion, axonal fluid fraction, fractional anisotropy, axial diffusion of extra-axonal fluid, mean kurtosis, relative anisotropy, radial kurtosis and tortuosity of the diffusion trajectory. Conclusion: Diffusion-kurtosis magnetic resonance imaging is a promising technique that allows obtaining additional differential information in the case of metastatic lesions of the brain matter, especially those from an undetected primary focus.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Natalia V. Garanina
N.N. Blokhin National Medical Research Center of Oncology
Author for correspondence.
Email: Garanina.natalia.v@gmail.com
ORCID iD: 0000-0002-3036-2753
SPIN-code: 6662-1649
Russian Federation, Moscow
Michail B. Dolgushin
Federal Center of Brain Research and Neurotechnologies
Email: mdolgushin@mail.ru
ORCID iD: 0000-0003-3930-5998
SPIN-code: 6388-9644
MD, PhD, Professor
Russian Federation, MoscowLiudmila M. Fadeeva
N.N. Burdenko National Scientific and Practical Center for Neurosurgery
Email: lmf@nsi.ru
ORCID iD: 0000-0002-3240-5585
Russian Federation, Moscow
Eduard L. Pogosbekyan
N.N. Burdenko National Scientific and Practical Center for Neurosurgery
Email: epogosbekyan@nsi.ru
ORCID iD: 0000-0002-4803-6948
Russian Federation, Moscow
Denis V. Sashin
N.N. Blokhin National Medical Research Center of Oncology
Email: denchegs70@gmail.com
ORCID iD: 0000-0003-0431-2610
MD, PhD
Russian Federation, MoscowEmilia A. Nechipay
N.N. Blokhin National Medical Research Center of Oncology
Email: e.nechipay@ronc.ru
ORCID iD: 0000-0002-3785-7070
MD, PhD
Russian Federation, MoscowAndrey V. Dvoryanchikov
Federal Center of Brain Research and Neurotechnologies
Email: dvoryanchikov.a@fccps.ru
ORCID iD: 0009-0009-0678-7821
Russian Federation, Moscow
References
- Практические рекомендации по лекарственному лечению больных с метастатическими опухолями головного мозга RUSSCO, 2014. [Practical recommendations for the drug treatment of patients with metastatic brain tumors RUSSCO, 2014. (In Russ).] Режим доступа: https://rosoncoweb.ru/standarts/RUSSCO/2014/06a.pdf?ysclid=lmdjfbl5m2230205456. Дата обращения: 15.08.2023.
- Lowery FJ, Yu D. Brain metastasis: Unique challenges and open opportunities. BBA Rev Cancer. 2017;1867:49–57. doi: 10.1016/j.bbcan.2016.12.001
- Eichler AF, Chung E, Kodack DP, et al. The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol. 2011;8:344–356. doi: 10.1038/nrclinonc.2011.58
- Ostrom QT, Wright CH, Barnholtz-Sloan JS. Brain metastases: Epidemiology. Handb Clin Neurol. 2018;149:27–42. doi: 10.1016/B978-0-12-811161-1.00002-5
- Первичные опухоли центральной нервной системы. Клинические рекомендации [интернет]. 2020. [Primary tumors of the central nervous system. Clinical recommendations [Internet]. 2020. (In Russ).] Режим доступа: https://cr.minzdrav.gov.ru/recomend/578_1?ysclid=lmdjjmxe9r61285653. Дата обращения: 15.08.2023.
- Cagney DN, Martin AM, Catalano PJ, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: A population-based study. Neuro-Oncol. 2017;19:1511–1521. doi: 10.1093/neuonc/nox077
- Насхлеташвили Д.Р., Банов С.М., Бекяшев А.Х., и соавт. Практические рекомендации по лекарственному лечению пациентов с метастазами в головном мозге // Злокачественные опухоли. Практические рекомендации RUSSCO #3s2, 2022. 2022. Т. 12, № 3s2. С. 141–154. [Naskhletashvili DR, Banov SM, Bekyashev AH, et al. Practical recommendations for the drug treatment of patients with brain metastases. Malignant Tumors. Practical recommendations RUSSCO #3s2; 2022. 2022;12(3s2):141–154. (In Russ).] doi: 10.18027/2224-5057-2022-12-3s2-141-154
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Central Nervous System Cancers, version 2.2022 [2022 Sept. 29].
- Lee EJ, Ahn KJ, Lee EK, et al. Potential role of advanced MRI techniques for the peritumoural region in differentiating glioblastoma multiforme and solitary metastatic lesions. Clin Radiol. 2013;68(12):e689–e697. doi: 10.1016/j.crad.2013.06.021
- Svolos P, Kousi E, Kapsalaki E, et al. The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives. Cancer Imaging. 2014;14(1):20. doi: 10.1186/1470-7330-14-20
- Steven AJ, Zhuo J, Melhem ER. Diffusion kurtosis imaging: An emerging echnique for evaluating the microstructural environment of the brain. Am J Roentgenol. 2014;202(1): W26–W33. doi: 10.2214/AJR.13.11365
- Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20:26–41. doi: 10.1038/s41568-019-0205-x
- Pardridge WM. The blood-brain barrier: Bottleneck in brain drug development. NeuroRX. 2005;2:3–14. doi: 10.1602/neurorx.2.1.3
- Carvalho R, Paredes J, Ribeiro AS. Impact of breast cancer cells secretome on the brain metastatic niche remodeling. Semin Cancer Biol. 2020;60:294–301. doi: 10.1016/j.semcancer.2019.10.011
- Rodrigues G, Hoshino A, Kenific CM, et al. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat Cell Biol. 2019;21:1403–1412. doi: 10.1038/s41556-019-0404-4
- Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Canc Cell. 2017;31:326–341. doi: 10.1016/j.ccell.2017.02.009
- Lah TT, Novak M, Breznik B. Brain malignancies: Glioblastoma and brain metastases. Semin Cancer Biol. 2020;60:262–273. doi: 10.1016/j.semcancer.2019.10.010
- Lugassy C, Kleinman HK, Engbring JA, et al. Pericyte-like location of GFP-tagged melanoma cells: Ex vivo and in vivo studies of extravascular migratory metastasis Am J Pathol. 2004;164:1191–1198. doi: 10.1016/S0002-9440(10)63207-5
- Sleeman JP, Nazarenko I, Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer. 2011;128: 2511–2526. doi: 10.1002/ijc.26027
- Baliyan V, Das CJ, Sharma R, Gupta AK. Diffusion weighted imaging: Technique and applications. World J Radiol. 2016; 8(9):785–798. doi: 10.4329/wjr.v8.i9.785
- Kälin RE, Cai L, Li Yu, et al. TAMEP are brain tumor parenchymal cells controlling neoplastic angiogenesis and progression. Cell Systems. 2021;12(3):248–262.e7. doi: 10.1016/j.cels.2021.01.002
- Helpern JA, Adisetiyo V, Falangola MF, et al. Preliminary evidence of altered gray and white matter microstructural development in the frontal lobe of adolescents with attention-deficit hyperactivity disorder: A diffusional kurtosis imaging study. J Magn Reson Imaging. 2011;33(1):17–23. doi: 10.1002/jmri.22397
Supplementary files
